Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcineurin is a highly conserved, calcium (Ca²⁺)- and calmodulin-dependent serine/threonine protein phosphatase that plays a central role in cellular signal transduction, especially in immune function and cardiovascular physiology. It is a heterodimer composed of a catalytic subunit (Calcineurin A) and a regulatory subunit (Calcineurin B). Calcineurin dephosphorylates specific substrates in response to increased intracellular Ca²⁺ levels, with a key function being the activation of T cells via NFAT dephosphorylation. It is a target for immunosuppressant drugs like cyclosporin A and tacrolimus, used to prevent organ transplant rejection and treat autoimmune diseases. Dysregulation of calcineurin is implicated in neurodegenerative and cardiovascular diseases.
Calcineurin inhibitors (cyclosporin A and tacrolimus) bind to cyclophilin or FKBP12, respectively, and the resulting complex inhibits calcineurin activity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcineurin (CN).